Inovio Pharmaceuticals
INO
#9484
Rank
HK$0.67 B
Marketcap
HK$8.22
Share price
-7.08%
Change (1 day)
-33.02%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2025 (TTM): -HK$0.85 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are HK$0.18 Million. In 2024 the company made an earning of -HK$0.84 Billion, an increase over its 2023 earnings that were of -HK$1.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.85 Billion0.46%
2024 -HK$0.84 Billion-20.03%
2023 -HK$1.05 Billion-51.56%
2022 -HK$2.17 Billion-8.26%
2021 -HK$2.36 Billion95.4%
2020 -HK$1.21 Billion36.62%
2019 -HK$0.89 Billion20.19%
2018 -HK$0.74 Billion10.94%
2017 -HK$0.67 Billion9.59%
2016 -HK$0.61 Billion118.9%
2015 -HK$0.28 Billion-10.67%
2014 -HK$0.31 Billion83.32%
2013 -HK$0.17 Billion
2011 -HK$0.18 Billion15.64%
2010 -HK$0.16 Billion37.7%
2009 -HK$0.11 Billion2.19%
2008 -HK$0.11 Billion-14.09%
2007 -HK$0.13 Billion19.12%
2006 -HK$0.11 Billion9.62%
2005 -HK$95.35 Million5.77%
2004 -HK$90.15 Million73.08%
2003 -HK$52.09 Million12.75%
2002 -HK$46.2 Million
2000 -HK$69.92 Million53.93%
1999 -HK$45.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$262.74 B-31,140.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$128.05 B-15,227.85%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$79.81 B-9,529.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$76.72 B-9,163.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$175.59 B-20,844.37%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$77.49 B-9,254.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-HK$21.56 Million-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$2.70 B-419.30%๐Ÿ‡บ๐Ÿ‡ธ USA